Literature DB >> 10644496

Construction and virulence testing of a collagenase mutant of Clostridium perfringens.

M M Awad1, D M Ellemor, A E Bryant, O Matsushita, R L Boyd, D L Stevens, J J Emmins, J I Rood.   

Abstract

Clostridium perfringens produces several extracellular toxins and enzymes, including an extracellular collagenase or kappa toxin that is encoded by the colA gene. To determine if the ability to produce collagenase was a significant virulence factor in cases of gas gangrene or clostridial myonecrosis that are caused by C. perfringens, a chromosomal colA mutant was constructed by homologous recombination and subsequently virulence tested in the mouse myonecrosis model. The results clearly indicate that loss of the ability to produce collagenase does not alter the ability of the mutant to establish a virulent infection. By contrast, infection with a mutant unable to produce alpha-toxin led to a marked decrease in virulence. These results indicate that collagenase is not a major determinant of virulence in C. perfringens -mediated clostridial myonecrosis. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644496     DOI: 10.1006/mpat.1999.0328

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  16 in total

1.  Cloning of alpha-beta fusion gene from Clostridium perfringens and its expression.

Authors:  Jia-Ning Bai; Yan Zhang; Bao-Hua Zhao
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

2.  Crystallization and preliminary X-ray characterization of the catalytic domain of collagenase G from Clostridium histolyticum.

Authors:  Ulrich Eckhard; Dorota Nüss; Paulina Ducka; Esther Schönauer; Hans Brandstetter
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-04-24

Review 3.  Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease.

Authors:  Francisco A Uzal; John C Freedman; Archana Shrestha; James R Theoret; Jorge Garcia; Milena M Awad; Vicki Adams; Robert J Moore; Julian I Rood; Bruce A McClane
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

4.  Structural requirement in Clostridium perfringens collagenase mRNA 5' leader sequence for translational induction through small RNA-mRNA base pairing.

Authors:  Nozomu Obana; Nobuhiko Nomura; Kouji Nakamura
Journal:  J Bacteriol       Date:  2013-04-12       Impact factor: 3.490

5.  Regulation of virulence by the RevR response regulator in Clostridium perfringens.

Authors:  Thomas J Hiscox; Anjana Chakravorty; Jocelyn M Choo; Kaori Ohtani; Tohru Shimizu; Jackie K Cheung; Julian I Rood
Journal:  Infect Immun       Date:  2011-03-14       Impact factor: 3.441

6.  Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene.

Authors:  M M Awad; D M Ellemor; R L Boyd; J J Emmins; J I Rood
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 7.  Animal models to study the pathogenesis of human and animal Clostridium perfringens infections.

Authors:  Francisco A Uzal; Bruce A McClane; Jackie K Cheung; James Theoret; Jorge P Garcia; Robert J Moore; Julian I Rood
Journal:  Vet Microbiol       Date:  2015-02-25       Impact factor: 3.293

8.  Proteome and transcriptome analysis of the virulence genes regulated by the VirR/VirS system in Clostridium perfringens.

Authors:  Takeshi Shimizu; Kensuke Shima; Ken-ichi Yoshino; Kazuyoshi Yonezawa; Tohru Shimizu; Hideo Hayashi
Journal:  J Bacteriol       Date:  2002-05       Impact factor: 3.490

9.  Comparative Genomics of Clostridium perfringens Reveals Patterns of Host-Associated Phylogenetic Clades and Virulence Factors.

Authors:  Renae R Geier; Thomas G Rehberger; Alexandra H Smith
Journal:  Front Microbiol       Date:  2021-06-09       Impact factor: 5.640

10.  Comparative transcription analysis and toxin production of two fluoroquinolone-resistant mutants of Clostridium perfringens.

Authors:  Sunny Park; Miseon Park; Fatemeh Rafii
Journal:  BMC Microbiol       Date:  2013-03-01       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.